Energy Fuels stock falls today as UUUU pulls back after uranium sales beat, new contracts
30 December 2025
1 min read

Energy Fuels stock falls today as UUUU pulls back after uranium sales beat, new contracts

NEW YORK, December 30, 2025, 13:43 ET — Regular session

Shares of Energy Fuels Inc fell 3.5% to $14.55 in afternoon trading on Tuesday. The uranium miner lagged peers, with Uranium Energy down about 1.9% while Cameco was little changed and MP Materials slipped about 1.3%. Energy Fuels traded about 5.9 million shares and ranged between $14.30 and $15.28.

The pullback matters because uranium stocks have been swinging on fresh evidence of supply discipline, contract signings and realized pricing. Investors want proof that producers can turn high commodity prices into durable cash flow, not just headlines.

Energy Fuels is a live case study. It sells into both near-term spot markets and longer-dated contracts, a mix that can smooth revenue but also caps some upside.

In a company update on Monday, Energy Fuels said it exceeded its 2025 guidance for finished uranium production, mined ore and uranium concentrate sales. It expects to sell 360,000 pounds of U3O8 — uranium oxide concentrate, often called “yellowcake” — in the fourth quarter for about $27 million of gross uranium sales at a weighted average price of $74.93 per pound. “Strong uranium production is critical to America’s economic and national security,” CEO Mark S. Chalmers said. 1

The company also said it completed two new long-term uranium sales contracts with U.S. nuclear power generators for deliveries from 2027 to 2032, using a hybrid pricing structure that blends an escalated base price with spot-price exposure within floor-and-ceiling bands. Energy Fuels forecast about 780,000 to 880,000 pounds of U3O8 sales into its long-term contract portfolio in 2026 and said its six long-term contracts total 2.41 million to 4.41 million pounds for 2027–2032; it also expects cost of goods sold to start dropping in the first quarter of 2026 as lower-cost uranium is sold. It said the White Mesa Mill produced more than one million pounds of finished U3O8 in 2025 and plans to mill roughly 250,000 pounds a month through the first half of 2026 before shifting to commercial-scale production of the heavy rare earths dysprosium and terbium. 2

Energy Fuels rose 2.94% on Monday to close at $15.07 after touching $16.00, then gave back ground in Tuesday’s session. The stock opened at $15.15 on Tuesday and was last trading below that level. 3

For investors, the contract mechanics are the key nuance. Hybrid pricing can support cash flow with a base component while still leaving some upside if uranium prices rise into delivery, but floors and ceilings limit the extremes.

Cost is the other swing factor. A drop in cost of goods sold — the direct costs tied to producing and processing uranium — would widen margins if realized prices hold, and it puts extra weight on how quickly lower-cost feed reaches sales.

The rare-earth angle adds optionality and complexity. Investors will be watching whether the company can execute on two commodity cycles at once, and how capital and operating priorities shift if one market tightens while the other cools.

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
AI stocks today: Nvidia AI21 buyout talk hits tape as Meta climbs on Manus deal
Previous Story

AI stocks today: Nvidia AI21 buyout talk hits tape as Meta climbs on Manus deal

Natural gas price steadies near $4 as UNG stock climbs; traders await fresh U.S. storage data
Next Story

Natural gas price steadies near $4 as UNG stock climbs; traders await fresh U.S. storage data

Go toTop